GlobeNewswire by notified

Philips highlights AI-powered integrated diagnostic approach at ECR 2023

Share

March 1, 2023

Fully interoperable smart imaging systems and informatics solutions connect teams in radiology, oncology, cardiology and pathology to enhance clinical confidence and advance precision in diagnosis and treatment

Vienna, Austria and Amsterdam, the Netherlands –Royal Philips (NYSE: PHG, AEX: PHIA), a global leader in health technology, today announced its radiology portfolio of smart connected imaging systems and vendor-neutral integrated radiology workflow solutions featured at the European Congress of Radiology (ECR) international meeting (March 1-5, Vienna, Austria). Visitors to Philips @The Blue Level at ECR, the largest exposition space at the Congress, will experience how Philips’ AI-powered technology turns data into actionable insights to increase diagnostic confidence and improve clinical outcomes, enhancing patient and staff experience, driving operational efficiency, and helping lower the cost of care.

“At this year’s ECR, together with our customer partners, Philips will demonstrate how our latest AI-powered integrated smart diagnostic systems and informatics solutions can help reduce clinical complexity and drive operational efficiency to address workforce shortages and staff burnout, all while optimizing the right care pathway for patients,” said Bert van Meurs, Chief Business Leader of Image Guided Therapy and Precision Diagnosis at Philips. “With our AI-enabled technology, we can automate and accelerate routine tasks to generate patient-centric insights from large volumes of data to help improve productivity and enhance patient outcomes. Underpinning each of our innovations at ECR is Philips’ commitment to delivering sustainable, resilient diagnostic solutions that help hospitals receive ongoing value from their investments.”

Smart connected imaging systems powered by leading clinical and AI technology
Philips will showcase its latest innovations connecting radiology, cardiology, pathology and oncology across MR, CT, diagnostic X-ray and ultrasound, including MR SmartSpeed, the next-generation imaging technology that leverages Philips’ state-of-the-art speed engine and an award-winning Artificial Intelligence (AI) [1] reconstruction technology that boosts speed and image quality. In partnership with Leiden University Medical Center (Leiden, The Netherlands) Philips is innovating with AI to further speed up and improve MR examinations, with the aim to reduce scan times to less than five minutes and to reconstruct detailed MR images despite patient or internal organ movement. The approach is already showing promising results in leading hospitals worldwide.

“In systematic research studies, we have seen strong evidence of the ability of SmartSpeed to significantly accelerate acquisition times for knee and spine examinations without compromising image quality, with scan times that can be reduced up to 64% for certain sequences,” said Dr. Andra-Iza Iuga, Department of Radiology at the University Hospital of Cologne, Germany.  “Since musculoskeletal (MSK) exams make up a large part of all MR procedures, these acceleration benefits have the potential to result in significant operational cost reductions and we are currently successfully implementing the results of our research studies into our clinical routine.”

Integrated radiology workflow solutions driving operational efficiency
Optimizing clinical workflows can help eliminate waste and allow hospitals to use their resources more efficiently, which translates into improved patient flow and delivery of higher quality care to patients. At ECR, Philips will spotlight its advanced technology to simplify and connect workflows to help reduce variability and staff workload, drive operational efficiency, and enhance the patient experience.

For more information on Philips’ fully integrated radiology portfolio of imaging and informatics solutions being featured at ECR, visit the Philips ECR Press Backgrounder. Read more about Philips’ partnerships with public and private customers, peers, and industry-leading global organizations to help reduce the environmental impact of radiology.

Join Philips in person at the Blue Level at ECR, or virtually via the Philips interactive online radiology experience and follow @PhilipsLiveFrom for #ECR2023 updates throughout the event.

[1] According to the definition of AI from the EU High-Level Expert Group. 

For further information, please contact:

Kathy O’Reilly 
Philips Global Press Office 
Tel.:+1 978 221 8919 
E-Mail: kathy.oreilly@philips.com
Twitter: @kathyoreilly

About Royal Philips

Royal Philips (NYSE: PHG, AEX: PHIA) is a leading health technology company focused on improving people's health and well-being through meaningful innovation. Philips’ patient- and people-centric innovation leverages advanced technology and deep clinical and consumer insights to deliver personal health solutions for consumers and professional health solutions for healthcare providers and their patients in the hospital and the home. Headquartered in the Netherlands, the company is a leader in diagnostic imaging, ultrasound, image-guided therapy, monitoring and enterprise informatics, as well as in personal health. Philips generated 2022 sales of EUR 17.8 billion and employs approximately 77,000 employees with sales and services in more than 100 countries. News about Philips can be found at www.philips.com/newscenter.

Attachments

To view this piece of content from www.globenewswire.com, please give your consent at the top of this page.
To view this piece of content from ml-eu.globenewswire.com, please give your consent at the top of this page.

About GlobeNewswire by notified

GlobeNewswire by notified
GlobeNewswire by notified
One Liberty Plaza - 165 Broadway
NY 10006 New York

https://notified.com

GlobeNewswire by notified is one of the world's largest newswire distribution networks, specializing in the delivery of corporate press releases financial disclosures and multimedia content to the media, investment community, individual investors and the general public.

Subscribe to releases from GlobeNewswire by notified

Subscribe to all the latest releases from GlobeNewswire by notified by registering your e-mail address below. You can unsubscribe at any time.

Latest releases from GlobeNewswire by notified

Shareholders approve all resolutions on the agendas of Tenaris’s Annual General Meeting and Extraordinary General Meeting of Shareholders1.5.2024 23:10:26 CEST | Press release

LUXEMBOURG, May 01, 2024 (GLOBE NEWSWIRE) -- Tenaris S.A. (NYSE and Mexico: TS and EXM Italy: TEN) announced that its annual general meeting of shareholders and its extraordinary general meeting of shareholders, both held on April 30, 2024, approved all resolutions on their agendas. Among other resolutions adopted at the annual general meeting, shareholders acknowledged the Company’s 2023 annual report, containing the consolidated management report and the related management certifications and external auditors’ reports, and the Company’s 2023 annual sustainability report, containing the non-financial statement required by Luxembourg law. The shareholders also approved the consolidated financial statements as of and for the year ended December 31, 2023, and the annual accounts as at December 31, 2023. The annual general meeting also approved an annual dividend of US$0.60 per share (or US$1.20 per ADR), which represents an aggregate sum of approximately US$0.7 billion, and which include

CNH is changing its NYSE ticker symbol to “CNH” on May 201.5.2024 22:30:00 CEST | Press release

Basildon, May 1, 2024 CNH Industrial (NYSE: CNHI) announces that the Company’s common shares listed on the New York Stock Exchange (NYSE) will begin trading under the symbol “CNH” effective Monday, May 20, 2024. This will replace the Company’s current ticker symbol, “CNHI”, marking a return to both our original ticker symbol “CNH” – used until 2013 – and our identity as a leading pureplay provider of equipment, technology and services for agriculture and construction. CNH Industrial N.V. will remain the name of the legal entity. The ticker symbol for the Company’s 3.850% Notes due 2027 will also change from “CNHI 27” to “CNH 27” at the same time. No action is required by the Company's shareholders or bondholders with respect to the ticker symbol changes, as the Company’s common stock and notes will continue to be listed on the NYSE and their CUSIP numbers will remain unchanged. CNH Industrial (NYSE: CNHI) is a world-class equipment and services company. Driven by its purpose of Breakin

Koelis Announces New Product Release at AUA 2024 to Offer Innovative AI-Enhanced MRI Fusion Biopsy Workflow1.5.2024 20:48:50 CEST | Press release

GRENOBLE, France and PRINCETON, N.J., May 01, 2024 (GLOBE NEWSWIRE) -- Koelis, SAS (“Koelis” or the “Company”, www.koelis.com), a leader and innovator in prostate care, announced today the release of new features at the prestigious American Urological Association Annual Meeting in San Antonio, TX. Koelis will be holding live and interactive demos at its booth #951 from May 2nd to May 5th to demonstrate its novel capacity integrating AI-enhanced prostate MRI features into its exclusive Trinity platform. The Koelis Trinity® system enables urologists to perform 3D targeted “fusion biopsy” in prostate cancer. Trinity integrates 3D ultrasound imaging with proprietary MRI-US fusion image guidance that features the Company’s unique prostate motion tracking software (OBT Fusion®). The compact Koelis Trinity® system does not require interfaces with either external ultrasound equipment or external sensors. The versatility of the Trinity platform is enabling Koelis to lead the ongoing paradigm sh

Awilco Drilling Plc: Keppel denied leave to appeal the ruling of the AR2 arbitration tribunal1.5.2024 20:34:14 CEST | Press release

Further to the stock exchange releases of 23 November 2023 and 15 January 2024 from Awilco Drilling PLC ("Awilco Drilling") regarding the termination of the newbuilding contract between Awilco Rig 2 Pte. Ltd. ("AR2") and Keppel FELS Limited ("KFELS") for the construction of a semi-submersible drilling rig, hull number B382. The Company has today received the decision of the High Court refusing Keppel’s application for leave to appeal the award of the AR2 arbitration tribunal. The award is in AR2's favour in an amount of USD 43.0 million plus interest and legal costs. Unless the parties can mutually agree, the tribunal will issue a further award related to interest and costs. We will revert once the award has been received and the amounts of interest and costs have been determined. Aberdeen, 1 May 2024 For further information please contact: Eric Jacobs, CEO of Awilco Drilling PLC Phone: +47 9529 2271 Cathrine Haavind, Investor Relations of Awilco Drilling PLC Phone: +47 9342 8464 Email

Idorsia increases the consent fee in connection with the proposed restructuring of the 2024 convertible bond1.5.2024 18:00:00 CEST | Press release

Ad hoc announcement pursuant to Art. 53 LR The proposed consent fee will be increased to 8’000’000 Idorsia shares. All other matters as proposed on April 23, 2024, remain unchanged.The bondholder meeting will take place on May 6, 2024, in order to vote on the proposals published on April 23, 2024. Allschwil, Switzerland – May 1, 2024 Idorsia Ltd (SIX: IDIA) today announced that in relation to the bondholder meeting for holders of its outstanding convertible bonds maturing on July 17, 2024 (ISIN: CH0426820350) (the Bonds), Idorsia has improved the consent fee to 8’000’000 Idorsia shares up from 5’000’000. Other elements of the proposal published on April 23, 2024 such as the (i) amendment to the conversion price to CHF 6.00 (from currently CHF 33.95), (ii) extension of the maturity date by six months to January 17, 2025 and (iii) giving Idorsia the option to call the Bonds at par, in full or in part, at any time upon giving ten trading days' notice, remain unchanged. Bondholders can acc

HiddenA line styled icon from Orion Icon Library.Eye